Innate Immune Mechanisms Governing Subclinical Malaria in Children
控制儿童亚临床疟疾的先天免疫机制
基本信息
- 批准号:10460703
- 负责人:
- 金额:$ 73.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-01 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:15 year oldATAC-seqAddressAffectAfricaAfrica South of the SaharaAgeAgonistAnopheles GenusAnti-Inflammatory AgentsAreaBinding SitesBiological AssayBiomassBloodBlood specimenCellsChildChromatinChronicClinicalCommunitiesComplexCountyCulicidaeCytokine GeneCytometryDNADNA sequencingDataDevelopmentDiseaseElementsEnhancersEnrollmentEpidemiologyEpigenetic ProcessEquilibriumFeverGene ExpressionGene Expression ProfileGenesGoalsHigh-Throughput Nucleotide SequencingHomeostasisImmuneImmunomodulatorsIn VitroIndividualInfectionInflammation MediatorsInflammatoryInflammatory ResponseInnate Immune ResponseInterferon Type IIInterferonsInterleukin-1 ReceptorsInterleukin-10Interleukin-6KenyaKnowledgeLegal patentLongitudinal cohort studyMalariaMeasurementModificationParasitemiaParasitesPathway interactionsPeripheral Blood Mononuclear CellPlasmaPlasmodium falciparumPopulationProductionProteinsPublic HealthRNA analysisRegulator GenesRegulatory PathwayRegulatory T-LymphocyteResearchRoleSchool-Age PopulationSiteSourceSpecificitySymptomsT-Lymphocyte SubsetsTNF geneTestingTissue-Specific Gene ExpressionToll-like receptorsTransposaseWorkadaptive immunityage groupantagonistchromatin immunoprecipitationcohortcomparison groupcytokineeffector T cellepigenetic markerepigenomeinnate immune mechanismsinnate immune pathwaysinsightmonocytepromoterresponserural areasextranscription factortranscriptome sequencingtransmission processvectorvector mosquito
项目摘要
ABSTRACT
Subclinical (asymptomatic) malaria with Plasmodium falciparum (Pf) is common in children who live in moderate-
to-high transmission areas of sub-Saharan Africa. Although subclinical malaria may be submicroscopic, affected
school-age children (ages 8-15 years) often have positive blood smears that include millions of parasites per mL
of blood. While subclinical malaria is typically attributed to acquired adaptive immunity that tightly controls the Pf
biomass, patent parasitemia (blood smear+) exceeds any reasonable estimate of the pyrogenic threshold. How
is it possible to remain without fever and overt malaria symptoms with patent parasitemia? In contrast to
symptomatic malaria, temporally persistent (chronic) subclinical malaria seems to be maintained by a complex
balance of pro-inflammatory and anti-inflammatory cytokines and immune cells. The scientific premise of this
proposal is that epigenetic modifications of innate immune cells, including blood monocytes (Mo), modulate
inflammatory pathways underlying subclinical malaria. Furthermore, we hypothesize that an immune
homeostasis network involving anti-inflammatory Pf-induced type 1 T regulatory cells (Tr1) and IL-10 as well as
enhanced IL-1RA production suppress innate immune inflammatory pathways. Subclinical malaria is of high
epidemiologic significance as parasitemia persists for months in schoolchildren who serve as the major reservoir
of gametocytes required to sustain Pf transmission to local anopheline vectors. Indeed, it is estimated that ~
60% of new mosquito infections can be attributed to this demographic. To test our hypotheses, we will enroll
Kenyan schoolchildren (ages 8-15) in a longitudinal cohort study to compare and analyze differences in immune
parameters between those with A) chronic subclinical malaria (Pf+ smear at baseline and who remain afebrile
despite repeatedly smear+ x 16 weeks) relative to B) children who develop febrile clinical malaria up to 2 weeks
after an afebrile Pf+ smear. The specificity of immune parameters for chronic Pf exposure in these cohorts will
be interrogated by comparison to age and sex matched children residing in a nearby highlands area where
malaria endemicity is ~ zero. PBMC and isolated Mo from children will be analyzed by RNA-seq to determine
activated gene expression pathways. We will define the differences in immune cell subsets, the transcription
factors that are activated and their effector cytokine expression profiles using mass cytometry (CyTOF). In
addition, we will use chromatin immunoprecipitation (ChIP) DNA sequencing to determine if the epigenomes of
children with chronic subclinical malaria are modified in order to silence proinflammatory genes or conversely,
to activate anti-inflammatory ones. Finally, we will identify and compare by Assay for Transposase-Accessible
Chromatin with high-throughput Sequencing (ATAC-seq) open chromatin sites in key gene expression pathways
in Mo from the comparator groups and align these regions with RNA-seq data from the same child. The
successful completion of this project should give us new and important insights as to the mechanism of
subclinical malaria and how this disease state can be modified to facilitate malaria eradication.
抽象的
恶性疟原虫(PF)的亚临床(无症状)疟疾常见于生活在中等的儿童中
撒哈拉以南非洲的最高传播区域。尽管亚临床疟疾可能是微观的,但受到影响
学龄儿童(8-15岁)经常有阳性污渍,包括每毫升数百万寄生虫
血液。尽管亚临床疟疾通常归因于获得的自适应免疫,该免疫力紧紧控制了PF
生物量,专利寄生虫(血液涂片+)超过了热原阈值的任何合理估计。如何
是否可以保持发烧和明显的疟疾症状,并具有专利寄生虫的症状?与
有症状的疟疾,暂时持久(慢性)亚临床疟疾似乎是由复合物维持的
促炎和抗炎细胞因子和免疫细胞的平衡。科学前提
建议是对先天免疫细胞的表观遗传修饰,包括血单核细胞(MO),调节
亚临床疟疾的炎症途径。此外,我们假设是免疫
涉及抗炎PF诱导的1 T型调节细胞(TR1)和IL-10的稳态网络以及
增强的IL-1RA产生抑制了先天免疫炎症途径。亚临床疟疾很高
作为寄生虫的流行病学意义在学童中持续了几个月,他们是主要水库
将PF传播到局部瞬间向量所需的配子细胞。确实,据估计〜
60%的新蚊子感染可以归因于这种人群。为了检验我们的假设,我们将注册
肯尼亚学童(8-15岁)在一项纵向队列研究中,以比较和分析免疫的差异
a)慢性亚临床疟疾(基线时的PF+涂片并保持在Afebrile)之间的参数
尽管反复涂片+ x 16周)相对于b)患有发热临床疟疾的儿童长达2周
经过afebrile PF+涂片。在这些队列中,免疫参数对慢性PF暴露的特异性将
与居住在附近的高地地区的年龄和性匹配的孩子相比,可以通过询问
疟疾流行〜零。 RNA-Seq将分析来自儿童的PBMC和分离的MO
活化的基因表达途径。我们将定义免疫细胞子集的差异,转录
使用质量细胞术(CytoF)激活的因素及其效应子细胞因子表达谱。在
此外,我们将使用染色质免疫沉淀(CHIP)DNA测序来确定是否表观构想
为了使促炎基因沉默或相反,患有慢性亚临床疟疾的儿童被修饰
激活抗炎作用。最后,我们将通过测定转座酶访问来识别和比较
具有高通量测序(ATAC-SEQ)的染色质(ATAC-SEQ)在关键基因表达途径中开放染色质位点
在MO中,比较组组中,并将这些区域与来自同一孩子的RNA-Seq数据对齐。这
该项目的成功完成应该为我们提供有关机制的新重要见解
亚临床疟疾以及如何修饰这种疾病状态以促进疟疾消除。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Douglas T Golenbock其他文献
Douglas T Golenbock的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Douglas T Golenbock', 18)}}的其他基金
Neisseria gonorrhoeae exploits host interferon epsilon to establish infection in the female urogenital tract
淋病奈瑟菌利用宿主干扰素ε在女性泌尿生殖道中建立感染
- 批准号:
10655520 - 财政年份:2021
- 资助金额:
$ 73.77万 - 项目类别:
Neisseria gonorrhoeae exploits host interferon epsilon to establish infection in the female urogenital tract
淋病奈瑟菌利用宿主干扰素ε在女性泌尿生殖道中建立感染
- 批准号:
10317367 - 财政年份:2021
- 资助金额:
$ 73.77万 - 项目类别:
Neisseria gonorrhoeae exploits host interferon epsilon to establish infection in the female urogenital tract
淋病奈瑟菌利用宿主干扰素ε在女性泌尿生殖道中建立感染
- 批准号:
10435574 - 财政年份:2021
- 资助金额:
$ 73.77万 - 项目类别:
Inflammasome activation in modulation of Alzheimer's Disease by alcohol
酒精调节阿尔茨海默氏病中炎症小体的激活
- 批准号:
10673213 - 财政年份:2020
- 资助金额:
$ 73.77万 - 项目类别:
Inflammasome activation in modulation of Alzheimer's Disease by alcohol
酒精调节阿尔茨海默氏病中炎症小体的激活
- 批准号:
10471334 - 财政年份:2020
- 资助金额:
$ 73.77万 - 项目类别:
Inflammasome activation in modulation of Alzheimer's Disease by alcohol
酒精调节阿尔茨海默氏病中炎症小体的激活
- 批准号:
10264088 - 财政年份:2020
- 资助金额:
$ 73.77万 - 项目类别:
Mechanisms of type I IFN enhanced gonococcal infection
I型干扰素增强淋球菌感染的机制
- 批准号:
9979327 - 财政年份:2020
- 资助金额:
$ 73.77万 - 项目类别:
Role of inflammasomes in Alzheimer's Disease
炎症小体在阿尔茨海默病中的作用
- 批准号:
10167924 - 财政年份:2018
- 资助金额:
$ 73.77万 - 项目类别:
相似国自然基金
面向图神经网络ATAC-seq模体识别的最小间隔单细胞聚类研究
- 批准号:62302218
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于ATAC-seq策略挖掘穿心莲基因组中调控穿心莲内酯合成的增强子
- 批准号:82260745
- 批准年份:2022
- 资助金额:33.00 万元
- 项目类别:地区科学基金项目
基于ATAC-seq策略挖掘穿心莲基因组中调控穿心莲内酯合成的增强子
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
基于单细胞ATAC-seq技术的C4光合调控分子机制研究
- 批准号:32100438
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
基于单细胞ATAC-seq技术的C4光合调控分子机制研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Mechanisms of androgen-dependent Wolffian duct differentiation
雄激素依赖性沃尔夫管分化机制
- 批准号:
10633606 - 财政年份:2023
- 资助金额:
$ 73.77万 - 项目类别:
A democratized platform for mapping the spatial epigenome in tissue
用于绘制组织空间表观基因组图谱的民主化平台
- 批准号:
10822023 - 财政年份:2023
- 资助金额:
$ 73.77万 - 项目类别:
Multimodal omics approach to identify health to cardiometabolic disease transitions
多模式组学方法确定健康状况向心脏代谢疾病的转变
- 批准号:
10753664 - 财政年份:2023
- 资助金额:
$ 73.77万 - 项目类别: